UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 861177
NEW YORK, NY
Position in MDGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,398,786
+$4,942,298 QoQ
Shares Held
32,403
+36.2% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 411 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. MDGL ranks #32 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in MDGL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,398,786 | 32,403 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $12,456,488 | 23,796 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $13,886,477 | 23,846 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $10,767,499 | 23,476 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,047,792 | 39,809 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,732,213 | 26,363 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $8,497,397 | 27,538 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,744,385 | 22,356 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,894,453 | 24,609 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,801,312 | 14,235 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,293,691 | 14,235 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,311,226 | 15,826 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,574,032 | 15,472 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,748,244 | 15,472 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $1,081,043 | 16,634 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,190,659 | 16,634 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,219,629 | 12,430 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,053,316 | 12,430 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $991,788 | 12,430 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,210,804 | 12,430 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,382,934 | 11,823 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,078,458 | 9,701 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $1,114,160 | 9,384 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $975,647 | 8,615 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $239,801 | 3,592 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||